Burlington vs Pfizer: Founders, CEOs and History
Burlington was founded in 1972 by Monroe Milstein and is led by Michael O'Sullivan. Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla.
Company facts
Burlington
- Founded
- 1972
- Headquarters
- Burlington, New Jersey
- Current CEO
- Michael O'Sullivan
- Employees
- 83,309
Pfizer
- Founded
- 1849
- Headquarters
- New York, New York
- Current CEO
- Albert Bourla
- Employees
- 75,000
Founders
Burlington
Monroe Milstein
Monroe G. Milstein grew up in his family's wholesale outerwear business in New York.
Pfizer
Charles Pfizer
Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.
Charles Erhart
Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…
CEOs and their tenures
Burlington
- Monroe Milstein1972–2006
Founder and Chief Executive Officer
Milstein opened the first Burlington Coat Factory in Burlington, New Jersey, in 1972, broadened it from discount coats into year-round family apparel, shoes, baby and home goods, and took it public in 1983.
Source - Mark Nesci2006–2008
Chief Executive Officer
A 37-year Burlington veteran, Nesci became CEO in 2006 after Bain Capital took the company private for about $2.06 billion. He retired in December 2008, remaining an equity investor and senior adviser to the board.
Source - Tom Kingsbury2008–2019
President and Chief Executive Officer
A former Kohl's senior executive, Kingsbury was hired by Bain Capital in December 2008 to revamp buying, inventory management and the supply chain.
Source - Michael O'Sullivan2019–present
Chief Executive Officer
O'Sullivan joined from Ross Stores, where he spent 16 years and finished as president and COO, and became CEO around September 16, 2019.
Source
Pfizer
- Ian Read2010–2018
Chief Executive Officer
He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.
Source - Albert Bourla2019–present
Chairman and Chief Executive Officer
A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
Source - Dave Denton2022–2026
Chief Financial Officer
As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.
Source - Chris Boshoff2025–present
Chief Scientific Officer and President, Research & Development
He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.
Source - Cecile Guegan2026–present
Interim Chief Financial Officer
She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.
Source
Timeline: Burlington and Pfizer side by side
1849Pfizer
Pfizer Founded
Charles Pfizer and Charles Erhart founded the company in Brooklyn.
1944Pfizer
Penicillin Scale-Up
Pfizer helped industrialize penicillin production during World War II.
1972Burlington
Burlington Coat Factory opens
Monroe Milstein bought a coat outlet in a former factory building in Burlington, New Jersey, and sold brand-name coats at discount prices, the start of Burlington Coat Factory.
1983Burlington
First public offering
Burlington Coat Factory Warehouse Corporation went public for the first time, funding expansion from a regional discounter into a national chain with year-round apparel, shoes, baby and home departments.
1989Burlington
Cohoes Specialty Stores acquired
Burlington bought the Cohoes Specialty Stores off-price chain from upstate New York, including a 50 percent stake in the Cohoes Commons building; a few stores still traded as Cohoes Fashions decades later.
1998Pfizer
Viagra Approved
The FDA approved Viagra in 1998.
2000Pfizer
Warner-Lambert Deal
Pfizer acquired Warner-Lambert, adding Lipitor.
2006Burlington
Bain Capital takes Burlington private
Bain Capital acquired Burlington Coat Factory for about $2.06 billion, ending 34 years of Milstein family control. Long-time executive Mark Nesci became chief executive.
2008Burlington
Tom Kingsbury named CEO
Former Kohl's executive Thomas Kingsbury became president and CEO in December 2008, succeeding Mark Nesci, and began overhauling buying, inventory management and the supply chain.
2013Burlington
Return to the stock market
Burlington Stores priced its IPO on October 2, 2013, selling 13.3 million shares at $17 each for about $226 million, and listed under the ticker BURL.
2019Burlington
Michael O'Sullivan becomes CEO
Former Ross Stores president and COO Michael O'Sullivan succeeded Tom Kingsbury as CEO around September 16, 2019, and later launched the Burlington 2.0 plan of leaner inventories and smaller stores.
2019Pfizer
Albert Bourla becomes CEO
Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
2020Burlington
Online sales end and stores close for the pandemic
On March 5, 2020, Burlington said it would shut its e-commerce business. Days later pandemic lockdowns closed its stores, and fiscal 2020 revenue fell to $5.76 billion with a $216.5 million net loss.
2020Pfizer
BioNTech COVID Vaccine Partnership
Pfizer and BioNTech brought Comirnaty through emergency authorization.
2023Burlington
Bed Bath & Beyond leases
Burlington won 44 Bed Bath & Beyond leases for $12 million at the June 2023 bankruptcy auction, the largest share of the 109 sold, and later reported 62 former Bed Bath & Beyond leases in total.
2023Pfizer
Seagen Acquisition
Pfizer completed the $43 billion Seagen acquisition.
2025Burlington
Joann leases
After Joann's second bankruptcy, Burlington agreed in April 2025 to take over 45 Joann store leases, many of which became part of its fiscal 2026 opening program.
2025Pfizer
Chris Boshoff Becomes CSO
Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
2025Pfizer
Metsera Acquisition
Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.
2025Pfizer
FY2025 Revenue Base
Pfizer reported $62.579 billion of FY2025 revenue.
2026Burlington
Record fiscal 2025 results
Burlington reported fiscal 2025 total revenue of $11.57 billion and net income of $610.2 million, and ended the year on January 31, 2026, with 1,212 stores.
2026Burlington
Tariff refunds put into prices
In the second quarter of fiscal 2026, sales rose 11 percent to $2.998 billion. Burlington received $55 million in tariff refunds and said it would reinvest them in lower prices; the store count reached 1,287.
2026Burlington
Headquarters move to Philadelphia announced
On September 3, 2026, Burlington said it will invest $370 million to move its headquarters from Burlington Township, New Jersey, to Schuylkill Yards in Philadelphia, in phases from late 2028 or early 2029.
2026Pfizer
Innovent Oncology Collaboration
Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.
Acquisitions
Burlington
- Joann store leases2025Undisclosed
- Bed Bath & Beyond store leases2023$12M
- Burlington Coat Factory (taken private by Bain Capital)2006$2.1B
- Cohoes Specialty Stores (Cohoes Fashions)1989Undisclosed
Pfizer
- Metsera, Inc.2025$7B
- Seagen Inc.2023$43B
- Medivation Inc.2016$14B
- Wyeth2009$68B
- Pharmacia Corporation2003$60B
- Warner-Lambert Company2000$111B
Questions about Burlington vs Pfizer
Who is the CEO of Burlington Stores, Inc. and Pfizer Inc.?
Burlington Stores, Inc. is led by Michael O'Sullivan and Pfizer Inc. is led by Albert Bourla. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Burlington Stores, Inc. founded vs Pfizer Inc.?
Pfizer Inc. was founded in 1849 — 123 years before Burlington Stores, Inc., which was founded in 1972. Pfizer Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Burlington Stores, Inc..
How many employees does Burlington Stores, Inc. have compared to Pfizer Inc.?
Burlington Stores, Inc. employs approximately 83,309 people, while Pfizer Inc. employs approximately 75,000. Burlington Stores, Inc. has the larger workforce at 83,309 employees, compared to Pfizer Inc.'s 75,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Burlington Stores, Inc. and Pfizer Inc. headquartered?
Both Burlington Stores, Inc. and Pfizer Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Burlington Stores, Inc. and Pfizer Inc.?
Burlington Stores, Inc. was founded by Monroe Milstein. Pfizer Inc. was founded by Charles Pfizer, Charles Erhart.
Which company has a longer operating history — Burlington Stores, Inc. or Pfizer Inc.?
Pfizer Inc. has been operating for approximately 177 years, making it the more established of the two companies. Burlington Stores, Inc. has been in operation for around 54 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Burlington vs Pfizer overview